From robotic blood-drawing to ultrasound-based brain–computer interfaces, this week’s MedTech deals underscore continued investor confidence in high-impact medical technologies. Capital is flowing toward companies advancing regulatory pathways, clinical studies, and global commercialization strategies.
Vitestro raises...
From robotic blood-drawing to ultrasound-based brain–computer interfaces, this week’s MedTech deals underscore continued investor confidence in high-impact medical technologies. Capital is flowing toward companies...
XCath announced that it secured $30 million in its Series C financing round to support its endovascular robotic technology.
Crescent Enterprises and Dr. Fred Moll,...
Gestala, a China-based deep-tech startup developing brain-computer interface (BCI) technology, announced $21.69 million in funding.
The funding came through an Angel Round and set a...
Vitestro has raised $70m to advance development and broaden the commercialisation of its autonomous blood-drawing robot.
The Dutch company’s oversubscribed Series B financing round saw...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...
Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy.
The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...
From robotic blood-drawing to ultrasound-based brain–computer interfaces, this week’s MedTech deals underscore continued investor confidence in high-impact medical technologies. Capital is flowing toward companies...
XCath announced that it secured $30 million in its Series C financing round to support its endovascular robotic technology.
Crescent Enterprises and Dr. Fred Moll,...
Gestala, a China-based deep-tech startup developing brain-computer interface (BCI) technology, announced $21.69 million in funding.
The funding came through an Angel Round and set a...
Vitestro has raised $70m to advance development and broaden the commercialisation of its autonomous blood-drawing robot.
The Dutch company’s oversubscribed Series B financing round saw...